Skip to main content

LUNG ADENOCARCINOMA

Tracking # 20-1057790

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

LUNG ADENOCARCINOMA IS THE MOST COMMON PRIMARY LUNG CANCER SEEN IN THE UNITED STATES. IT FALLS UNDER THE UMBRELLA OF NON-SMALL CELL LUNG CANCER (NSCLC) AND HAS A STRONG ASSOCIATION WITH PREVIOUS SMOKING. WHILE INCIDENCE AND MORTALITY HAVE DECLINED, IT REMAINS THE LEADING CAUSE OF CANCER DEATH IN THE UNITED STATES. ADENOCARCINOMA OF THE LUNG USUALLY EVOLVES FROM THE MUCOSAL GLANDS AND REPRESENTS ABOUT 40% OF ALL LUNG CANCERS. IT IS THE MOST COMMON SUBTYPE TO BE DIAGNOSED IN PEOPLE WHO HAVE NEVER SMOKED. LUNG ADENOCARCINOMA USUALLY OCCURS IN THE LUNG PERIPHERY, AND IN MANY CASES, MAY BE FOUND IN SCARS OR AREAS OF CHRONIC INFLAMMATION. THIS ACTIVITY DESCRIBES THE PATHOPHYSIOLOGY OF ADENOCARCINOMA OF THE LUNG AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN ITS MANAGEMENT.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I